Ranier Technology
Founded Year
1995Stage
Other Investors | AliveAbout Ranier Technology
CAdisc is a unique, entirely polymeric Total Disc Replacement system for the treatment of degenerative disc disease in the lumbar and cervical spine. CAdisc-Lchar(2122) is designed to relieve pain and restore physiological quality of motion in the lumbar spine.
Missing: Ranier Technology's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Ranier Technology's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Ranier Technology Patents
Ranier Technology has filed 7 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/5/2008 | 6/23/2015 | Bones of the vertebral column, Spinal nerves, Skeletal system, Ligaments of the torso, Orthopedic surgical procedures | Grant |
Application Date | 5/5/2008 |
|---|---|
Grant Date | 6/23/2015 |
Title | |
Related Topics | Bones of the vertebral column, Spinal nerves, Skeletal system, Ligaments of the torso, Orthopedic surgical procedures |
Status | Grant |
Latest Ranier Technology News
Nov 28, 2018
Written by Shayna Korol | November 27, 2018 | Print | Email The now-defunct Ranier Technology sold spinal implants that allegedly moved and eroded in patients, according to The Guardian . Here are six things to know: 1. Ranier Technology received CE safety marks for its Cadisc-L and Cadisc-C implants, which were certified by the British Standards Institution in 2010 and 2011, respectively. The implants were then marketed to hospitals across Europe for degenerative disc disease treatment. 2. Approximately half of the patients who received the Cadisc-L implants have undergone further surgery after the discs disintegrated or moved in their backs, according to the Implant Files investigation, which was coordinated by the International Consortium of Investigative Journalists and involved The Guardian and BBC's Panorama. 3. A customized Cadisc-L disc was implanted in baboons and detailed in a Orthopaedic Proceedings study. According to the Implant Files investigation, the discs were misplaced in the baboon trials. 4. The results of human trials have not been published but ran for six months before Ranier submitted a CE mark application. 5. Ranier chose to seek approval in Europe before the U.S., allegedly to use the CE mark approval to get FDA clearance. The FDA asked for more data to support the approval application. 6. The company dissolved in 2018. In a statement to The Guardian, Ranier founder Geoffrey Adams said the Cadisc-L devices used in humans were not the same ones used in the baboon trials. He claimed clinical tests in patients had gone well, and the company, "decided unilaterally, and as a precaution, to formally withdraw Cadisc-L from the market, which it did on March 31, 2014," after four patients underwent revision surgery. More articles on devices:
Ranier Technology Frequently Asked Questions (FAQ)
When was Ranier Technology founded?
Ranier Technology was founded in 1995.
What is Ranier Technology's latest funding round?
Ranier Technology's latest funding round is Other Investors.
Who are the investors of Ranier Technology?
Investors of Ranier Technology include F&C Asset Management, FirstVentures, Alliance Trust Equity Partners and Technomark Medical Ventures.
Who are Ranier Technology's competitors?
Competitors of Ranier Technology include NeoChord, BioWave, Autonomic Technologies, Ortho Kinematics, DFine, LDR Holding, AxioMed, Biomimedica, Gentis, Baxano and 22 more.
Compare Ranier Technology to Competitors
Facet Solutions has developed a total replacement for the facet joint to treat back pain from hypertrophy.
Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine, which causes back pain. The company's first patented product, DiscCell, is a breakthrough injectable biomaterial that augments or replaces the diseased nucleus pulposus of the spinal disc.
Applied Spine Technologies is a spine company focused on developing implantable dynamic stabilization systems for the treatment of chronic back pain.
Disc Dynamics has developed the DASCORTM Disc Arthroplasty System, an innovative, minimally invasive nucleus replacement treatment for patients suffering from chronic low back pain caused by Degenerative Disc Disease (DDD).
Spinelab is a privately held company dedicated entirely to the development of a new generation of spinal motion preservation devices. Spinelab is the manufacturer and distributor of the CE-marked implant and instrument system Elaspine for the treatment of degenerative lumbar spine disease.
SpinalMotion is a medical device company focused on designing, developing and marketing advanced artificial discs for use in the spine. Its Kineflex Technology is intended to preserve motion in the spine for patients suffering from degenerative disc disease (DDD) in the cervical and lumbar spine.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.